Evaluation of Efficacy of a Cashew Apple Extract on Weight Management and Associated Metabolic Risk Factors in Overweight/Obese Volunteers

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

66 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-07-31

Study Completion Date

2016-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the efficacy and safety of a cashew apple extract on weight management and associated metabolic risk factors in overweight/obese volunteers, versus placebo, after 12 weeks of treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Medifast 5 & 1 Plan

NCT01211301

Obesity Body Weight Weight Loss +2 more

COMPLETED NA

Impact of Beta-glucan Supplementation During Calorie and Carbohydrate-restricted Diet on Body Weight and Body Fat Loss, Appetite, and Gastrointestinal Appetite Hormones.

NCT07299942

Overweight and Obese Women

RECRUITING NA

Appetite Suppression Trial With Polydextrose

NCT02064205

Body Weight Non-restrained Eaters

COMPLETED NA

Efficacy of a Nutritive Bar, in Reduction of Weight, Body Fat and Control of Appetite

NCT05104151

Overweight or Obesity

COMPLETED NA

Evaluation of Botanicals for Mechanisms Related to Appetite and Fat Metabolism

NCT02333461

Overweight Obesity

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Weight Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cashew apple extract (Cashewin)

Group Type ACTIVE_COMPARATOR

Cashew apple extract (Cashewin)

Intervention Type DIETARY_SUPPLEMENT

6 capsules per day (2 capsules 3 times per day, to be taken before breakfast, lunch and diner, each capsule containing 200 mg of Cashewin) during 12 weeks

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

6 capsules per day (2 capsules 3 times per day, to be taken before breakfast, lunch and diner) during 12 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cashew apple extract (Cashewin)

6 capsules per day (2 capsules 3 times per day, to be taken before breakfast, lunch and diner, each capsule containing 200 mg of Cashewin) during 12 weeks

Intervention Type DIETARY_SUPPLEMENT

Placebo

6 capsules per day (2 capsules 3 times per day, to be taken before breakfast, lunch and diner) during 12 weeks

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 27 ≤ BMI ≤ 35 kg/m²
* Abdominal obesity
* Acceptance to adhere to diet and physical activity recommendations while maintaining global lifestyle habits
* Stable body weight (\<5% variation) within the last 3 months prior to screening

Exclusion Criteria

* Allergy to nuts and products thereof and allergy to mango fruit
* Type I or II diabetes
* Smokers
* Severe chronic diseases
* History of bariatric surgery and eating disorders
* Use of weight management products or medications which could affect nutrients absorption, lipids or carbohydrates metabolism

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes